SCHEMBL5367000

SCHEMBL5367000

Cc1ccc(C=C2C(=O)Nc3ccc(N(C(C)O)C(C)O)cc32)s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
KMT2A Q03164 3/20 0.43
APP P05067 2/20 0.43
ALDH1A1 P00352 2/20 0.43
THRB P10828 1/20 0.43
HPGD P15428 1/20 0.43
RECQL P46063 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
SNCA P37840 1/20 0.43
EGFR P00533 2/20 0.41
PDPK1 O15530 5/20 0.40
RET P07949 2/20 0.40
JAK3 P52333 1/20 0.39
ERBB2 P04626 1/20 0.39
PDGFRB P09619 1/20 0.39
LRRK2 Q5S007 1/20 0.38
KDR P35968 1/20 0.38
POLB P06746 1/20 0.38
TLK2 Q86UE8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5370123 0.79 MEN1 (0.44) MAPTKMT2AAPPALDH1A1SNCA
SCHEMBL5358662 0.78 KDR (0.66) MAPTKMT2ARECQLNPSR1TDP1
SCHEMBL6001532 0.77 LRRK2 (0.58) EGFRRETERBB2PDGFRBLRRK2
SCHEMBL6001533 0.77 LRRK2 (0.58) EGFRRETERBB2PDGFRBLRRK2
SCHEMBL5363527 0.77 PDPK1 (0.65) PDPK1RETJAK3PDGFRBLRRK2
SCHEMBL14519109 0.77 TLK2 (0.57) KMT2APDPK1JAK3PDGFRBKDR
SCHEMBL5359077 0.77 EGFR (0.47) MAPTKMT2AALDH1A1THRBHPGD
SCHEMBL5364974 0.75 PDPK1 (0.46) MAPTKMT2AALDH1A1THRBHPGD
SCHEMBL5367195 0.74 PDPK1 (0.57) MAPTKMT2AALDH1A1THRBHPGD
SCHEMBL5368073 0.74 PDPK1 (0.61) PDPK1JAK3TLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
EP-1247803-A2 Indolinone compounds suitable for modulation of protein kinases Sugen, Inc. (US) 2002-10-09 EP disclosed